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The prevalence of cognitive impairments in the older adult population is growing. Finding 
treatment solutions to impede a cognitive decline can possibly lead to fewer cases of mild 
cognitive impairment, dementia, and Alzheimer’s disease. A Visual Paired Comparison (VPC) 
could serve as a tool to predict, monitor, and regulate people who are susceptible to a cognitive 
decline. The purpose of this study was to 1) to determine the validity of the Neurotrack 5-minute 
VPC test with the Neurotrack 30-minute VPC test, 2) to determine the test-retest reliability of the 
Neurotrack 5-minute VPC test, 3) to compare Neurotrack 5-minute VPC scores between 
individuals with cognitive impairment (Mild Cognitive Impairment and/or Alzheimer's Disease) 
to cognitively intact adults, 4) lastly to compare Neurotrack VPC results with other cognitive 
tasks (MoCA, NIH toolbox, Dual task) performed within the study. This study included older 
adults age 60+ split into cognitively intact individuals and cognitively impaired individuals 
based from the MoCA. Analysis was ran on 28 subject in which 11 were cognitively impaired 
(mean=.687; Std=.137) and 17 were cognitively intact (mean=.851; Std=.044). The relationship 
between 5-minute VPC and the 30-minute VPC revealed a positive associations for both the first 
(r=.504; p=.006) and second (r=.420; p=.019) time points/trials. No significant differences 
between the 2 time points/trials (p=.212) which indicates a reliable 5-minute VPC test. A 
significant difference was found between the groups (p=.000). Domain-specific cognitive 
functions were examined through other assessments, in which the 5-minute VPC test was 
correlated to each of these tests. This study suggests that VPC to be a potentially reliable tool to 
assess cognitive function. 
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As of January 2016 there are 46 million Americans ages 65 and older within the United 
States. This number is expected to grow to over 98 million by 2060. This increase in the total 
share of the population will be reflected by an increase of 15% to a staggering 24% (Mather, 
Jacobsen, & Pollard, 2015). This population increase will also be associated with an increase in 
age related diseases such as Alzheimer’s Disease and dementia. Dementia has been defined as a 
general term for a decline in mental ability severe enough to interfere with daily life such as 
severe memory loss (Alzheimers Association, 2018). Alzheimer's Disease (AD) is the most 
common type of dementia that causes problems with memory, thinking, and behavior. It is 
known that 75% of the cases of dementia are diagnosed as the AD. Dementia is thought to be a 
progressive disease, which typically starts with mild cognitive impairment (MCI). MCI is a 
syndrome defined as cognitive decline greater than that expected for an individual's age and 
education level but that does not interfere notably with activities of daily life (Gauthier et al., 
2006). Prevalence of Dementia and MCI is high among older adults. 15-20% of individuals 65 
years of age or older have MCI with approximately 32% of these individuals developing AD 
within the next 5 years.  (Jellinger & Attems, 2010; Alzheimers Association, 2018).  This makes 
dementia one of the most common diseases among the elderly. MCI has shown to have a high 
likelihood of progression toward dementia, and as cognitive abilities worsens with time, the 
presumed inevitability of institutionalization, disability, and mortality becomes more apparent.  
MCI, dementia, and AD impact much more than just the individual suffering with the 
disease. Families, friends, and caregivers are also affected by the large responsibility that is 
accompanied with cognitive decline. Physical, emotional, and economic strain brought forth by 




not only strain family, friends, and caregivers but often demands support from health, social, 
financial, and legal systems (World Health Organization, 2012).  
One of the most influential figures that the Alzheimer’s Association published states that 
early and accurate diagnosis could save 7.9 trillion dollars in medical and comprehensive care 
costs.  In the United States alone, every 65 seconds someone develops Alzheimer’s/dementia. 
These sobering statistics indicate a clear and alarming problem. The initial area for researchers to 
begin to try and solve this world wide problem needs to be establishing a functional measure to 
assess cognition. Luckily, research has been conducted that exhibits an association between eye 
movements and cognition levels. Until just recently, eye tracking could only be measured by 
using specific and expensive equipment. It has been determined that even low resolution web 
cameras, found on smartphones, tablets and computers/laptops, can track eye gaze accurately (Y. 
Lin, R. Lin, Y. Lin, & Lee, 2013). This technique affords clinicians the ability to utilize common 
web cameras as a tool for tracking eye movements for individuals that might be at risk for a 
cognitive decline.  
Changes in cognition can go unnoticed for many years; suggesting that process of a 
decline of cognition begins years before a clinical diagnostic confirmation (Small, 2000). There 
is not a practical and reliable approach to accurately detect cognitive changes in the early stages 
of MCI or dementia. Diagnoses of dementia rely on neurological exams, brain imaging, 
assessments on mental function, and reports from friends and family. The amount of energy and 
effort that goes into a diagnosis of MCI or AD is extremely excessive and needs a more practical 
approach. Visual paired comparison (VPC) is a validated memory recognition test with a 
potential to be used for detecting memory impairments. VPC compares the amount of time an 




are shown side by side. It can be inferred from the eye tracking data that VPC can possibly be 
used as a screening tool for early dementia (Crutcher et al., 2009). It also can serve as an 
assessment for detecting MCI in the early stages along with predicting the risks of an individual 
developing MCI/dementia. When VPC testing is done over time, it gives the ability to monitor 
changes in cognitive function.  
Recently a study was completed that validated a 30-minute VPC eye tracking assessment 
utilizing a built in web camera (Bott et al., 2017). One of the major drawbacks is the length of 
the assessment. A shorter edition of VPC could be used as a quick and efficient screening tool 
for cognitive deficiencies. A concise and accurate assessment could possibly lead to faster 
cognitive screening, beneficial interventions and eventually a remedy for this plaguing disease.  
Threats to Validity  
 Recruitment for this study primarily involved residents from a retirement home. Many 
participants have similar social and economic status. This could cause a threat to validity because 
of the lack of generalization when compared to the 65+ age group population. Another threat to 
the validity of this study is optical problems within the participants. As age increases so does the 
chances for developing eye related issues/diseases. Approximately 1 in every 3 people will 
develop some form of vision reducing eye disease by the age of 65 (Ganley & Roberts 1983). 
Making it an important factor when examining eye movements. Medical history questionnaires 
were completed and any participant who was diagnosed with any major optical problems were 
excluded from the study. Additional screening and research on vision impairments will be 
critical in preserving valid results for VPC. Results for this study depend on the willingness of 
participants to complete each battery to the best of their ability. If participants do not complete 




malfunctions could pose a threat to validity. Manual analysis of the VPC assessment was 
conducted to establish higher accuracy of results and help negate technological malfunctions.  
Limitations  
 The 30-minute VPC test was only be administered on the first trial, which could possibly 
allow for mental fatigue to occur.  The 30-minute VPC test was not be re-assessed during the 
follow-up testing session.  The participants that were scheduled to complete the Digit Symbol 
Coding Test and NIH Toolbox test after 30-minute VPC test might have effected scores. The 
crossover design used should help account for mental fatigue 
Delimitations 
 A total of 33 subjects participated in this study. Participants reported to either the 
Exercise Science Research Center at the University of Arkansas or Butterfield Trail Village.  
Participants that reported to the Exercise Science Research Center will be in an isolated room 
free from distractions with an administrator. Participants that reported to Butterfield Trail Village 
completed all the assessments in a quiet office free from distractions. There was cognitive 
assessments completed on paper, IPads, and Laptops. Trials were administered at least 14 days 
apart. 
Review of Literature 
Cognitive impairments are not part of normal aging but do impact a substantial 
population worldwide. In 2017, The World Health Organization stated that there are 50 million 
people worldwide with dementia with about 10 million new cases formed every year. With the 
abundance of new cases every year, this growing problem needs a resolution. Currently there is 
no treatment to cure dementia or change its progressive path. Additional research, treatment, and 




review of literature will highlight some scientific advancements with regard to assessing older 
adults with unimpaired and impaired cognitive abilities. Research efforts will be the preliminary 
action to cut down the major problem with screening, diagnosing, and treating cognitive decline.  
One of the most widely accepted tools used for estimating the risk of dementia is the 
CAIDE (cardiovascular risk factors, aging and dementia) model. CAIDE began in 1998 with the 
purpose of investigating the connection between social, lifestyle, and cardiovascular risk factors 
together with cognition, dementia, and structural changes in the brain. This model associates risk 
factors with points. The higher number of points, then the higher the risk for developing 
dementia within the next 20 years (Kivipelto et al., 2013). An abundance of research has been 
conducted surrounding the CAIDE model proving it to be a useful prediction tool. A large scale 
long term study was conducted to assess a diet, exercise, cognitive training, and vascular risk 
monitoring intervention and its effects in cognitive decline prevention. This multi-domain 
approach showed promising results that certain risk factors linked to dementia and AD could be 
modified (Nganda et al., 2015). A similar study set out to determine if the results from the 
previous study were reliable. Researchers determined that sociodemographic, socioeconomic 
status, cognition, cardiovascular factors, and cardiovascular comorbidity did not impact the 
response to the intervention group that was observed (Rosenberg et al., 2018). Thus, indicating 
that their results were valid and that individuals can exhibit beneficial effects on cognition from 
multi-domain interventions. This method for enhancing a healthier lifestyle can be applied to 
nearly all individuals. The beneficial effects of this study were not limited by age, sex, cognitive 
performance, level of education, household income, cardiovascular risk factors, or presence of 
cardiovascular comorbidity. Interventions targeting beneficial lifestyle changes prove to be 




evidence-based assessment to determine and track cognition levels used in accordance with a 
lifestyle intervention could possibly impede individuals from developing cognitive impairments.  
 MCI is considered to be the transitional phase between standard cognitive aging and 
dementia (Morris, 2012). Finding proper assessments to examine and compare cognitively intact 
to cognitively impaired individuals was the first major step to evaluating these groups. One of 
the first studies in this field was conducted by Daffner and colleagues (1992) in which they used 
the notion that dementia patients exhibit diminished curiosity and initiative. The researchers 
studied curiosity by tracking exploratory eye movements in response to visual stimuli. 
Individuals with AD distributed their viewing time equally between the two images that were 
shown to them. Subjects with AD spent the same amount of time on the incongruous stimuli 
compared to the congruous stimuli (41.5% versus 35.5%). This differed from the cognitively 
intact control, which spent more time viewing the incongruous stimuli compared to the 
congruous stimuli (50.7% versus 38.4%). These results led the authors to conclude that AD 
patients’ exhibit diminished curiosity that can be measured by exploratory eye movements. This 
finding guided the way for more research to be conducted on the significance of eye movement 
and cognition.  
 Years later, Visual Paired Comparison (VPC) was studied to test the potential usefulness 
of predicting the onset of AD. VPC is a behavioral recognition memory task that examines the 
proportion of time an individual spends viewing a novel picture compared to a previously seen 
image. It has been exhibited that cognitively intact individuals concentrate their attention to 
novel features (Loftus & Mackworth, 1978). Normal cognitively intact individuals spend more 
time inspecting new images while, cognitively impaired individuals spend an equal amount of 




in a study where eye movements were tracked when presented with novel and previously seen 
images.  Interestingly, with just a 2-second delay results between groups were similar. When the 
delayed was lengthened to 2 minutes, MCI patients spent 53% of their time viewing the new 
image compared to the control subjects who spent more than 70% of their time viewing the new 
image (Crutcher et al., 2009). This finding contributed to the theory that VPC tasks can be used 
as a tool to diagnose MCIs and possibly predict dementia onset. A similar study demonstrated 
this to be true as well as finding that researchers could distinguish between aged matched normal 
cognitive individuals and MCI subjects with 87% accuracy, 97% sensitivity, and 77% specificity 
(Lagun et al., 2011). This study validated Support Vector Machines (SVM), which use an 
automatic classification algorithm to determine eye gaze. This novel application detects eye 
movement patterns, specific fixations, saccades, and re-fixation. In a previous study, it was 
determined that cognitively intact individuals spent 10.8% of time looking at neither stimulus 
while, AD patients spent 23% (Daffner et al., 1992). The time spent viewing neither stimulus 
was later termed as the “grey area”.  The “grey area” also incorporates the time that is spent 
fixated between images, in which the SVM can also measure. This was a drastic improvement 
from the best available classification system that was used at the time, which could only 
distinguish individuals with a 67% accurate, 60% sensitive, and 73% specificity. Thus, 
reassuring a hopeful approach for detecting cognitive impairments. 
 The next problem to arise was the ability to reliably differentiate individuals who are not 
at risk of cognitive decline to those that are at risk. Since MCI individuals are not assured to 
develop AD or dementia it is difficult to accurately assess these individuals that are at higher risk 
for progressing. It has been concluded that MCI has a 6% to 25% chance of converting to AD 




immensely important to determine individuals who are at risk and those who are not. Zola and 
colleagues (2013), tracked elderly subjects with MCI and with unimpaired cognition for three 
years. This gave the researchers to ability to monitor and test elderly individuals with VPC over 
a lengthy span of time. In this study, Eight out of nine participants who exhibited a VPC score of 
50 or less converted to MCI or AD but no individuals with scores of 67 or higher on VPC 
converted to MCI or AD. A ROC curve was generated based on VPC scores and whether the 
individual’s diagnosis worsened over three years. The ROC curve displayed area under the curve 
of .903 indicating a powerful ability to discriminate between individuals who will and will not 
evolve to MCI or AD. Consequently, suggesting that VPC can serve as a formidable measure for 
an impending cognitive decline. 
 Many studies assessing the significance of VPC are using eye tracking systems that are 
set up within a lab and not easily accessible to many individuals. Without eye tracking 
instruments and trained technicians to properly administer VPC test, these measures would not 
be possible. Finding a practical, reliable, and valid method to combat this problem was the next 
step for VPC testing. A standard asset for most technological devices are built in web cameras. 
Web cameras are now commonly used on desktop/laptop computers, tablets, and smartphones. 
Practical alternatives to using expensive infrared eye tracking systems are warranted.  It is 
important to be certain that eye tracking through cameras built into smart devices can yield 
correct and reliable results. A recent study assessed whether a commercially high frame rate eye 
tracking camera system can be equivocally accurate to a built in web camera. The high frame 
rate eye tracker showed strong associations with the web camera in regards to VPC preference 
score. Along with a strong relationship on VPC preference score between the 3, 5, and 10 frames 




scoring of the VPC strongly correlated with the automated scoring of the high frame rate eye 
tracker camera during the same task (Bott et al., 2017). Interestingly throughout this study, 
researchers, had significantly less data quality issues using the built in web camera. Built in web 
cameras on smart devices can be highly accurate and less troublesome.  
 The purpose of this study was to 1) to determine the validity of the Neurotrack 5-minute 
VPC test with the Neurotrack 30-minute VPC test, 2) to determine the test-retest reliability of the 
Neurotrack 5-minute VPC test, 3) to compare Neurotrack 5-minute VPC scores between 
individuals with cognitive impairment (Mild Cognitive Impairment and/or Alzheimer's Disease) 
to cognitively intact adults, 4) lastly to compare Neurotrack VPC results with other cognitive 




In this study, a non-experimental, comparative research design was used. This design was 
appropriate for the comparison of scores within the adult group (60+ years of age). Cognitive 
assessments are compared between cognitively impaired adults and cognitively intact adults. The 
independent variable for this study are the groups in which the individuals are placed 
(cognitively intact group or cognitively impaired group). The dependent variables will be scores 
to Neurotrack VPC assessments and other cognitive tests: Montreal Cognitive Assessment 
(MoCA), Digit Symbol coding Test, NIH toolbox assessments, and Dual Task results.   
Participants 
All participants in this study are older adults’ age of 60+ years of age. Participants were 




will be individuals with intact cognition and cognitively impaired individuals as determined by 
the MoCA.  
Measures 
 MoCA. MoCA is a rapid screening instrument used for mild cognitive dysfunction, 
which served as an indicator for individuals for either intact or impaired cognitive abilities. This 
pencil and paper assessment challenges a variance of cognitive domains: attention and 
concentrations, executive functions, memory, language, visuoconstructional skills, conceptual 
thinking, calculations, and orientation. The test takes approximately 10 minutes. A score of 30 
possible points was obtained and if participants score ≤ 26 a guardian’s signature will be needed 
before their data can be used. Scores ≤ 26 and diagnoses of AD will place participants in the 
cognitively impaired group. Participants who score >26 will not need any further action for their 
data to be used. One study exhibited the MoCA has a sensitivity of 83% in detecting subjects 
with MCI and a sensitivity of 94% in detecting subjects with dementia  (Smith, Gildeh & 
Holmes, 2007). 
Digit Symbol Coding Test. A pencil paper test that will serve as another cognition 
assessment. This coding task will require participants to use a reference key that has digits 1-9 
matched with basic symbols. They will use this reference key to manually fill in the rows of 
blank spaces that are paired with a number. Participants will not be allowed to know how much 
time they are allotted, just instructed to fill in the rows in order as quickly as possible. After 90 
second the test will be concluded and a score will be given depending on the correct amount of 
symbols they placed in the boxes. This exam challenges information processing, visual 




screening. This test has demonstrated acceptable values for both retest reliability and practice 
effects of individual tests being >0.70 (Gonzalez-Blanch et al., 2011). 
NIH toolbox. The NIHTB-CB (cognitive battery) is a comprehensive set of 
measurements that can assess cognitive function from an IPad. The NIH toolbox tests will 
include: Flanker Inhibitory Control and Attention test, Dimensional Change Card Sort test, 
Pattern Comparison Processing Speed Test, Picture Sequence Memory Test. Before each test 
there will be a trial period in which the tasks will be demonstrated. Participants will then take 
part in practice sets to prove their understanding for the task. If participants are not able to 
successfully complete the practice set after three attempts, they will move onto the next test. The 
NIH toolbox is intended to measure neurological and behavioral function (NIH, 2017). The NIH 
toolbox convergent validity for all cognitive test ranged from r = 0.48 to r = 0.93 which means 
they are measuring there desired constructs (Weintraub et al., 2013).  
Flanker Inhibitory Control and Attention Test. This test will display arrows pointing 
in certain direction on the screen. The participants will be instructed to indicate which direction 
the middle arrow is pointing. Some of the time the arrows will point the same direction and 
sometimes the middle arrow will be facing the opposite direction. This will require the 
participant to focus on a specific stimulus while inhibiting attention to the stimuli flanking it. 
This test shows a high test-retest reliability of .96 with a convergent validity of .48 (Weintraub et 
al., 2013).  
Dimension Change Card Sort Change Test (DCCS). In his test participants will  
Presented with two target pictures. A cue word of “shape” or “color’ will appear on the screen. 
This cue word will indicate how the participant is supposed to match the images. If “shape’ 




color. This 30-item test will help with assessing cognitive flexibility and attention. The DCCS 
shows a high test-retest reliability of .94 with a convergent validity of .51 (Weintraub et al., 
2013). 
Pattern Comparison Processing Speed Test. Participants will be presented with two 
side by side pictures in which they will have to detect whether or not the pictures are the same or 
if they differ. This is a relatively short test that takes less than 90 seconds for the participant to 
finish. The picture items are simple and not too complex with hopes to solely measure processing 
speed. This test shows a high test-retest reliability of .82 with a convergent validity of .49 
(Weintraub et al., 2013). 
 Picture Sequence Memory Test. Participants will be shown a sequence of pictured 
objects and images with a particular order. Once the sequence concludes, images will get 
scrambled around the screen. The goal will be to replicate the sequence of pictured objects and 
activities. There will be two trial consisting of one trail of 15 pictures followed by one trial of 18 
pictures. There will be three novel pictures on the second trial. The intention for this test is to 
assess episodic memory. This test shows a test-retest reliability of .78 and with a convergent 
validity of .69 (Weintraub et al., 2013).  
 Visual Paired Comparison (VPC). There will be two different VPC test administered: 
Neurotrack’s 30-minute VPC test and Neurotrack’s 5-minute VPC test. The 30-minute VPC test 
is a passive test that requires relatively no instruction. Subjects are asked to keep relatively still 
while images are displayed on a laptop computer. The 5-minute VPC test is a shortened version 
that is classified as an active test because it will instruct the participants to focus on the new 




and store the participants face and eye movements. These recorded videos will then get analyzed 
by Neurotrack.  
Demographics. Height and weight were assessed using a stadiometer and balance beam 
scale. Height was measured to the closest 0.5 inch and weight was measured to the nearest .5 lbs. 
Participants had the option of completing a body composition using a duel-energy x-ray 
absorptiometry (DXA). DXA was only available at the Exercise Science Research center at the 
University of Arkansas. If Participants did not use DXA, body composition was estimated with 
height, weight, sex, and age.  
Dual Task. This physical and mental assessment will be conducted over a length of 20 
meters. It will be measured in a well-lit obstacle free location. For risk minimization participants 
that would usually use assisted walking devices will asked to complete this assessment with 
those devices. If participants are immobile, this portion of testing will be omitted. Timing gates 
will be setup at 5 and 15 meters. Subjects will be instructed to walk a full 20 meters to ensure no 
acceleration or deceleration occurred through the 5 and 15 meter timing gates. They will 
complete 4 different walking tests: 20-meter walk at usual speed, 20-meter walk at usual speed 
while doing a simple math problem, 20-meter walk at a fast pace, 20-meter walk at a fast pace 
while doing a simple math problem. Each of these trials were completed twice. The simple math 
problem is subtraction by 3 from a randomized 3-digit number. Times will be recorded to the 
nearest hundredth of a second. The dual task assessment has demonstrated a reliability of >0.75	  
(Yang et al., 2017). The aim is to determine how gait time is affected by cognitive abilities. 
Dual-task test have been proven to be a valid and reliable measure to assess working memory in 






Since IRB approval has been acquired, participants reported to either the Exercise 
Science Research Center at the University of Arkansas or a continued care retirement community 
in Fayetteville Arkansas. Participants reported for two separate trials at least 14 days apart. On 
the first visit, participants were asked to read and review an informed consent document. Once 
signed, research was able to be continued. Participants were then given a medical history 
questionnaire. This was followed by the Montreal Cognitive Assessment (MoCA), which was 
only assessed on the first visit. The informed consent, medical history questionnaire and MoCA 
are considered to be the preliminary requirements. The order of testing was randomly selected 
for all the participants and a crossover design for the two trials was used for the rest of the 
dependent variables to account for mental fatigue. This means participants that completed the 
Neurotrack VPC testing before the other cognitive assessments on the first trial, they then 
completed the cognitive assessments first on the second trial and vice versa.  
The Neurotrack VPC testing was completed on a laptop equipped with a web camera in 
which individuals first completed a 30-minute test, followed by a 5-minute test. Participants only 
completed the 30-minute VPC testing on their first visit and not their second. Participant’s faces 
were recorded throughout the test. The video was then analyzed and eye movements were 
tracked. Participants then started the next set of cognitive assessments with the Digit Symbol 
Substitution Test. In which, Subjects were required to fill in a series of symbols they need to 
correctly code within 90 seconds. The more symbols that were correctly coded corresponds to a 
higher score and better performance.  
An Ipad was involved with the NIH toolbox testing. Participants were taken through a 




were four NIH Toolbox assessments in which they completed in the same order for both trials. 
The order was Flanker Inhibitory Control and Attention Test, Dimension Change Card Sort 
Change Test, Pattern Comparison Processing Speed Test and lastly the Picture Sequence 
Memory Test. Before each of the assessments participants completed a practice trial to ensure 
they understand their objectives. Once all NIH Toolbox tests were completed trial one was 
concluded.  
The second trial was done at least 14 days after the first and the preliminary requirements 
were not repeated. Participants either started with the VPC testing or the additional cognitive 
measures depending on the order they were completed during the first trial. After this testing was 
done, additional demographic testing was then conducted on the participants. Height and weight 
were assessed using a stadiometer and balance beam scale. Height was measured to the closest 
0.5 inch and weight was measured to the nearest .5 lbs. Participants had the option of completing 
a body composition using a duel-energy x-ray absorptiometry (DXA). DXA was only available 
at the Exercise Science Research center at the University of Arkansas. If Participants did not use 
DXA, body composition was estimated with height, weight, sex and age. The last cognitive 
measure which was only completed on the second trial was the dual task walking test. 
Participants normal and fast walking times will be measured with and without the task if simple 
math problems to determine how an additional task affected gait. This concluded all of the 
assessments in the study.  
Data Analysis 
 A Pearson correlation was used to determine the validity of the 5-minute Neurotrack 
VPC test compared to the 30-minute Neurotrack VPC test. The test-retest reliability of the 5-




from the first trial compared to the second trial. To compare the 5-minute Neurotrack VPC test 
scores between individuals with cognitive impairments to cognitively intact adults an Anova 
repeated measures was conducted. To determine the association between VPC-5 scores with the 
other cognitive tasks (MoCA, NIH Toolbox, Dual task) a Pearson correlation was used with a 




 (Table 1) There were 33 subjects with an age of 60+ years who completed this study. 20 
subjects were classified as cognitively intact (MoCA > 26), while 13 subjects were classified as 
cognitively impaired by either clinically diagnosed memory problems or a MoCA < 26. 
Relationship Between 5-minute and 30-minute VPC Tests 
 The relationship between 5-minute VPC and the 30-minute VPC revealed a positive 
association. This indicates the 5-minute VPC to also be a valid measure for declarative memory. 
Both the first (Table 2; r=.504; p=.006) and second (Table 3; r=.420; p=.019) time points/trials 
for the 5-minute VPC revealed a significant correlation to the 30-minute VPC test. 
Test Re-test Reliability of 5-minute  
 A paired samples T-test was used to determine the reliability of the 5-minute VPC test. 
The T-test revealed no significant differences between the 2 time points/trials (p=.212). This 
indicates a reliable 5-minute VPC test. 
Comparing 5-minute VPC Test Between Groups 
 Analysis was ran on 28 subject in which 11 were cognitively impaired (mean=.687; 




analysis was used to determine any differences between the intact group and the impaired group. 
Our findings indicate a significant difference between the groups (p=.000).  
Associations Between 5-minute VPC Test and Cognitive Assessments  
 Another purpose of this study was to compare the 5 minute VPC test to other cognitive 
assessments that were performed during the study. Domain-specific cognitive functions were 
examined through other assessments, in which the 5-minute VPC test was correlated to each of 
these tests.  
On the initial day of testing (Table 2) significant relationships were not found between 
any of the NIHTB-CB. The MoCA, which was only taken on day 1, exhibited a significant 
relationship (r = .672; p = .000). A significant relationship was also found between the Digit 
Symbol test and 5-minute VPC test (r = .643; p = .000). On the second trial (>14 days; Table 3), 
significant relationships were found between the Flanker (r = .383; p = .044), PSPAC (r = .523; 
p = .004), PSMT (r = .586; p = .001), While the DCCS (r = .222; p = .256) did not. The digit 
symbol test(r = .750; p = .000) showed a significant relationship  
Dual –Task. This assessment was only performed on trial 2, There were no significant 
relationships with the DT and 5-minute VPC trial 1 testing, but there significant relationships 
found on trial 2 with the 5-minute VPC testing and DT habitual speed (r = -.385; p = .029)and 
DT fast pace (r = -.387; p = .031) when an simple subtraction task was involved.  
Discussion  
 This study had four main objectives which were 1) to determine the validity of the 5-
minute Neurotrack VPC test with the 30-minute Neurotrack VPC test, 2) to determine the test-
retest reliability of the 5-minute Neurotrack VPC test, 3) to compare 5-minute Neurotrack VPC 




Alzheimer's Disease) to cognitively intact adults, 4) lastly to compare Neurotrack VPC results 
with other cognitive tasks (MoCA, NIH toolbox, Dual task) performed within the study.  
 The first purpose of determining the validity of the 5-minute and the 30-minute VPC test 
revealed a moderate convergent validity between tests. Importantly, results from trial one and 
trial two revealed similar correlational values. Results from the 5-minute VPC test demonstrates 
a feasible alternative to the 30-minute VPC test for measuring visual recognition memory. While 
both test are assessing working memory ability there are some distinguishable differences. The 
30-minute VPC test has no instructions other than to look at the images on the screen. This test 
was also intended to only be taken once to achieve a baseline score. The 5-minute VPC test 
instructs the participants to focus on the image they have not seen before. This test should be 
considered more active rather than passive because of the basic qualities of the test. Furthermore, 
the active nature of this test reveals a significant benefit in which it can be taken repeatedly over 
time.  
 The second primary objective was to determine the test re-test reliability of the 5-minute 
VPC. The results revealed no statistical differences between the two time points. This signifies a 
strong test-re-test reliability of the 5-minute VPC test. Test re-test reliability ensures that 
individuals can take this assessment repeatedly over time without significant differences in 
cognitive scores.  
 The third purpose of this study was to compare the 5-minute VPC scores with the 
cognitively intact group and the cognitively impaired group. Statistics revealed a significant 
difference between the intact and the impaired groups. The 5-minute VPC test was able to 
determine differences and differentiate individuals who were classified as cognitively intact and 




indicating similar results within the two groups. Thus showing additional reliability for the 5-
minute VPC test. 
 The last purpose of the study was to compare the 5-minute VPC scores to the other 
cognitive assessments performed. The 5-minute VPC test had more significant correlations with 
cognitive batteries that were performed on second trial day. Three out of four NIHTB-CB test 
were significantly correlated (Flanker, PSPAC, and PSMT) on day 14 while none of the NIHTB-
CB were correlated with trial 1 testing. This possibly indicates some testing effects which can 
occur when tasks are repetitively practiced and results are changed or improved. The NIHTB-CB 
only have one version of each of the test and were repeated on both trial days. This repetitive 
testing for cognitive batteries has been proven to make assessments vulnerable to learning/testing 
effects and unlikely that these changes are associated to changes in cognitive abilities (Goldberg 
et al., 2015). Additional practice trials on the NIHTB-CB could possibly mitigate some of these 
testing effects for future studies. Advantageously, Testing effects are alleviated in the 5-minute 
VPC tests because of the substituted forms that were used on trial one and trial two. 
 A limitation displayed in this study was data quality issues from the VPC testing. The 
data quality issues included glare from glasses, electronic errors, and low lighting. Results were 
excluded from one older adult for the 30-minute VPC test, five older adults for the 5-minute 
VPC testing Trial 1, and one older adult for the 5-minute VPC testing Trial 2. The rest of the 
batteries that were performed by these participants were still included in the assessments because 
of the completion of both trials. Ecological validity was also a limitation of this study. Testing 
was done in a research setting which either included a private office or a secluded room instead 
of participants natural settings such as their home. Moreover, research needed to be conducted in 




amount of cognitively impaired individuals participated in the study. Future studies should 
include more cognitively impaired individuals to increase the ability assess different levels of 
impairment.  
 The 5-minute VPC test from Neurotrack shared many significant associations to other 
gold standard cognitive assessments. There are also beneficial differences that the 5-minute VPC 
test has exhibited such as scalability. Other assessments have been proven to be valid and 
reliable but need to be taken in person and with a trained professional. Instead of having to rely 
on trained professionals to administer cognitive exams, individuals can administer this 
assessment solely on their own. The alternate forms that are available in the 5-minute VPC test 
also allows for individuals to retake the assessment to track any cognitive changes. Yet another 
upside to the 5-minute VPC test is that individuals can take this examination anywhere that has 
internet connection and a smart device that has a camera built-in or attached. 
 In conclusion, this study exhibited moderate convergent validity between the 5-minute 
VPC and 30-minute VPC assessments. A strong test re-test reliability of the 5-minute VPC test 
was revealed. Significant differences were found between the cognitively intact and cognitively 
impaired groups and significant correlations were found between the 5-minute VPC test and 
other cognitive assessments. Results indicate a hopeful approach to screen and monitor cognitive 
health over time. The 5-minute VPC test is not intended to be a diagnostic test which would 
require additional research with larger samples of participants. Future studies should be done to 
examine effects of testing in common environments instead of isolated and unfamiliar places. 
Because of the minimal recruitment of cognitively impaired individuals in this study more 
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Table 1. Characteristics of the study cohort  
 Older Adults (n = 33) 




Education   
High School Graduate 6.1% 
Some College 15.2% 





Height (SD) 164.7 cm (10.3) 
Weight (SD) 71.3 kg (13.8) 
Cognitively Normal  
 
66.7% 
Cognitively Impaired  
 
33.3% 
 
